Levosimendan: a calcium-sensitizing agent for the treatment of patients with decompensated heart failure.
about
Therapeutic options for the management of the cardiorenal syndrome.Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.Comparative hemodynamic effects of levosimendan alone and in conjunction with 4-aminopyridine or calcium chloride in a rodent model of severe verapamil poisoning.Levosimendan does not improve cardiac output or blood pressure in a rodent model of propranolol toxicity when administered using various dosing regimens.Levosimendan infusion improves cardiac output but not blood pressure in a rodent model of severe metoprolol toxicity.Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity.
P2860
Levosimendan: a calcium-sensitizing agent for the treatment of patients with decompensated heart failure.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Levosimendan: a calcium-sensit ...... h decompensated heart failure.
@ast
Levosimendan: a calcium-sensit ...... h decompensated heart failure.
@en
type
label
Levosimendan: a calcium-sensit ...... h decompensated heart failure.
@ast
Levosimendan: a calcium-sensit ...... h decompensated heart failure.
@en
prefLabel
Levosimendan: a calcium-sensit ...... h decompensated heart failure.
@ast
Levosimendan: a calcium-sensit ...... h decompensated heart failure.
@en
P1476
Levosimendan: a calcium-sensit ...... h decompensated heart failure.
@en
P2093
Lasse Lehtonen
P2860
P2888
P304
P356
10.1007/S11897-004-0023-6
P577
2004-09-01T00:00:00Z